GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » Research & Development

Sophia Genetics (Sophia Genetics) Research & Development : $37.03 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sophia Genetics's Research & Development for the three months ended in Mar. 2024 was $9.39 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $37.03 Mil.

Sophia Genetics Research & Development Historical Data

The historical data trend for Sophia Genetics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics Research & Development Chart

Sophia Genetics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 15.02 18.59 26.58 35.37 36.97

Sophia Genetics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.33 8.89 8.98 9.76 9.39

Sophia Genetics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $37.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sophia Genetics  (NAS:SOPH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sophia Genetics Research & Development Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Sophia Genetics (Sophia Genetics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » Research & Development
Comparable Companies
LFMD TRHC CPSI CMAX TALK SPOK AUGX AMWL NUTX OPRX GEHC VEEV TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY TDOC
Traded in Other Exchanges
90B:Germany
Address
Rue du Centre 172, Saint-Sulpice, CHE, CH-1025
Website
https://www.sophiagenetics.com
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.